Immune effects and mechanisms of action of CpG motifs

By Krieg A.M.  

Vaccine, Vol. 19, Iss. 6, 2000-11 ,pp. : 618-622

Elsevier

Access to resources Recommend Favorite

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

By Weeratna R.D.   McCluskie M.J.   Xu Y.   Davis H.L.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1755-1762

Elsevier

Access to resources Recommend Favorite

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein

By Ioannou X.P.   Gomis S.M.   Karvonen B.   Hecker R.   Babiuk L.A.   van Drunen Littel-van den Hurk S.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 127-137

Elsevier

Access to resources Recommend Favorite

Poly-l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines

By Lingnau K.   Egyed A.   Schellack C.   Mattner F.   Buschle M.   Schmidt W.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3498-3508

Elsevier

Access to resources Recommend Favorite

CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)

By Hancock G.E.   Heers K.M.   Smith J.D.   Scheuer C.A.   Ibraghimov A.R.   Pryharski K.S.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4874-4882

Elsevier

Access to resources Recommend Favorite